SI-BONE Inc. Stock News

SI-BONE, Inc. (NASDAQ:SIBN) CEO Laura Francis sold 4,849 shares of the stock in a transaction dated Tuesday, November 16th. The stock was sold at an average price of $21.47, for a total transaction of $104,108.03. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Shares […]

SI-BONE, Inc. (NASDAQ:SIBN) Director Jeffrey W. Dunn sold 6,450 shares of the companys stock in a transaction on Tuesday, November 16th. The stock was sold at an average price of $21.47, for a total value of $138,481.50. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC []

Nuveen Asset Management LLC trimmed its holdings in SI-BONE, Inc. (NASDAQ:SIBN) by 22.0% in the second quarter, HoldingsChannel.com reports. The institutional investor owned 194,131 shares of the companys stock after selling 54,902 shares during the quarter. Nuveen Asset Management LLCs holdings in SI-BONE were worth $6,110,000 at the end of the most recent reporting period. []

SI-BONE's (SIBN) CEO Laura Francis on Q3 2021 Results - Earnings Call Transcript

Si-Bone (SIBN) delivered earnings and revenue surprises of -17.07% and -1.87%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

SANTA CLARA, Calif., Oct. 18, 2021 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced

The transition to an exclusive triangular implant policy by UnitedHealthcare, the nation's largest health insurer, is supported by over 100+ peer-reviewed publications, and comes as SI-BONE surpasses

SANTA CLARA, Calif., Aug. 23, 2021 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announce

SI-BONE Inc (NASDAQ: SIBN) reported Q2 sales of $22.2 million, beating the consensus of $21.96 million, representing a 58% Y/Y increase over the COVID-19 impacted 2020 period. U.S. revenue of $20.2

SI-BONE, Inc. (SIBN) CEO Laura Francis on Q2 2021 Results - Earnings Call Transcript

Si-Bone (SIBN) delivered earnings and revenue surprises of -7.69% and 0.77%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

Shares of SI-BONE (NASDAQ:SIBN) were flat in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share increased 4.55% over the past year to ($0.42), which misse

Record Second Quarter 2021 Worldwide Revenue of $22.2 million Record Second Quarter 2021 Worldwide Revenue of $22.2 million

Anthem is America's 2nd largest commercial health insurer and joins more than 35 other health plans to offer coverage exclusively for the triangular iFuse Implant System Anthem is America's 2nd larges

SANTA CLARA, Calif., July 20, 2021 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced